Frazier Healthcare, founded in 1991 to invest exclusively in healthcare, is a leading provider of growth equity and venture capital to high growth and emerging health care companies.
We employ a uniquely diversified, multi-pronged strategy of making control and growth capital investments in revenue generating, cash flow positive businesses that provide products and services across the healthcare industry, development stage investments in companies that are creating differentiated pharmaceutical products and limited, opportunistic investments in medical device businesses. We define growth capital investment opportunities as thesis-driven buyouts and recapitalizations with $5-$30 million in EBITDA while our biopharma
strategy is focused on functionally later stage assets that can be
positioned for an M&A exit in three to five years.
With over $1.8 billion under management across seven private investment funds, we have invested in over 140 companies across the entire healthcare business development spectrum. From seed stage venture investments to leveraged buyouts of highly profitable businesses, Frazier Healthcare has established itself among entrepreneurs and seasoned executives as a preferred partner to help create and grow successful health care companies.